Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening

By Spiekerkoetter Ute  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 5, 2010-10 ,pp. : 527-532

Springer Publishing Company

Access to resources Recommend Favorite

Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects

By Browning M.   Larson C.   Strauss A.   Marsden D.  

Journal of Inherited Metabolic Disease, Vol. 28, Iss. 4, 2005-06 ,pp. : 545-550

Springer Publishing Company

Access to resources Recommend Favorite

Pathophysiology of fatty acid oxidation disorders

By Bennett M.  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 5, 2010-10 ,pp. : 533-537

Springer Publishing Company

Access to resources Recommend Favorite

High activity of fatty acid oxidation enzymes in human placenta: Implications for fetal-maternal disease

By Oey N.   Den Boer M.   Ruiter J.   Wanders R.   Duran M.   Waterham H.   Boer K.   van der Post J.   Wijburg F.  

Journal of Inherited Metabolic Disease, Vol. 26, Iss. 4, 2003-06 ,pp. : 385-392

Springer Publishing Company

Access to resources Recommend Favorite

Update on mitochondrial fatty acid oxidation disorders

By Spiekerkoetter Ute   Mayatepek Ertan  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 5, 2010-10 ,pp. : 467-468

Springer Publishing Company

Access to resources Recommend Favorite